Ruthenium(II) complexes as bioorthogonal two-photon photosensitizers for tumour-specific photodynamic therapy against triple-negative breast cancer cells.
Chem Commun (Camb)
; 57(36): 4408-4411, 2021 May 04.
Article
em En
| MEDLINE
| ID: mdl-33949487
Herein, we developed the first Ru(ii) complex-based bioorthogonal two-photon photosensitizers. Through bioorthogonal labelling, they realize effective tumour-specific photodynamic therapy against triple-negative breast cancer cells.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Fotoquimioterapia
/
Rutênio
/
Fármacos Fotossensibilizantes
/
Fótons
/
Complexos de Coordenação
/
Neoplasias de Mama Triplo Negativas
/
Antineoplásicos
Limite:
Female
/
Humans
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article